Valuation: Medpace Holdings, Inc.

Market Cap 17.17B 14.96B 14.15B 12.86B 24.03B 1,644B 24.14B 169B 65.19B 836B 64.5B 63.07B 2,675B P/E 2026 *
35x
P/E 2027 * 32.1x
Enterprise Value 16.37B 14.26B 13.49B 12.26B 22.9B 1,568B 23.02B 161B 62.14B 797B 61.49B 60.12B 2,550B EV / Sales 2026 *
5.74x
EV / Sales 2027 * 5.26x
Free-Float
80.34%
Yield 2026 *
-
Yield 2027 * -
1 day-0.20%
1 week+5.49%
Current month+3.57%
1 month+3.02%
3 months+34.59%
6 months+35.16%
Current year+9.53%
1 week 589.44
Extreme 589.435
625.01
1 month 577.64
Extreme 577.64
629.69
Current year 373
Extreme 373
677.9
1 year 373
Extreme 373
677.9
3 years 227.21
Extreme 227.21
677.9
5 years 126.94
Extreme 126.945
677.9
10 years 21.76
Extreme 21.76
677.9
Manager TitleAgeSince
Chief Executive Officer 69 01/07/1992
Director of Finance/CFO 51 01/08/2021
Chief Tech/Sci/R&D Officer 65 01/09/2017
Director TitleAgeSince
Chairman 69 01/07/1992
Director/Board Member 55 01/07/2016
Director/Board Member 72 01/07/2016
Date Insider Type Main position Quantity % Market Cap. Importance
8/27/26 A Sell

Chief Executive Officer

-650 0.0023%
8/26/26 A Exercice

Director

11,574 0.0415%
8/26/26 A Sell

Chief Executive Officer

-4,000 0.0143%
Change 5-day change 1-year change 3-year change Capi.($)
-0.20%+5.49%+23.57%+119.72% 17.17B
+1.23%+1.87%-0.15%+9.57% 46.18B
+0.23%+4.72%+44.32%+27.27% 44.35B
+0.52%-3.15%+349.53%+520.09% 42.21B
+1.55%+3.41%+6.40%+76.45% 40.19B
+1.75%-0.28%+12.42%+41.11% 29.83B
-3.49%-8.49% - - 15.7B
+2.92%+8.40%+22.46%+38.87% 15.32B
-2.45%+2.41%-3.16%-35.16% 13.09B
+3.02%+3.18%+84.44%+35.50% 13.45B
Average +0.51%+1.41%+59.98%+92.60% 27.75B
Weighted average by Cap. +0.72%+1.56%+73.28%+116.78%

Financials

2026 *2027 *
Net sales 2.85B 2.48B 2.35B 2.14B 3.99B 273B 4.01B 28B 10.83B 139B 10.71B 10.47B 444B 3.03B 2.64B 2.5B 2.27B 4.24B 290B 4.26B 29.72B 11.49B 147B 11.37B 11.12B 472B
Net income 503M 438M 414M 376M 703M 48.13B 707M 4.93B 1.91B 24.46B 1.89B 1.85B 78.3B 547M 476M 451M 409M 765M 52.35B 769M 5.37B 2.08B 26.6B 2.05B 2.01B 85.16B
Net Debt -802M -699M -661M -601M -1.12B -76.84B -1.13B -7.88B -3.05B -39.05B -3.01B -2.95B -125B -1.25B -1.09B -1.03B -938M -1.75B -120B -1.76B -12.29B -4.75B -60.95B -4.7B -4.6B -195B
Logo Medpace Holdings, Inc.
Medpace Holdings, Inc. is a scientifically driven, global, full-service clinical contract research organization (CRO) providing phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. The Company partners with pharmaceutical, biotechnology, and medical device companies in the development and execution of clinical trials. The Company's drug development services focus on full-service Phase I-IV clinical development services and include development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support. The Company also provides bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. The Company's operations are principally based in North America, Europe, and Asia.
Employees
6,500
Date Price Change Volume
17/09/26 $615.18 -0.20% 226,115
16/09/26 $616.44 -0.65% 208,149
15/09/26 $620.48 +4.21% 303,860
14/09/26 $595.41 +1.34% 203,636
11/09/26 $587.52 +0.75% 159,087
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
13
Last Close Price
615.18USD
Average target price
581.83USD
Spread / Average Target
-5.42%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. MEDP Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!